Researchers have developed a new process that uses microwave flow reaction and recyclable solid catalysts to efficiently hydrolyze polysaccharides into simple sugars. The developed device utilizes a ...
Healthcare-focused AI startup Hippocratic AI has closed its Series B financing round, raising $141m, led by venture capital ...
Investor's Business Daily on MSN4h
Stocks Generating Improved Relative Strength: Alnylam PharmaceuticalsAlnylam Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative Strength Rating ...
Investor's Business Daily on MSN4h
Alkermes Shows Rising Relative Price Performance; Still Shy Of Key BenchmarkRating on Friday, rising from 69 to 74. Please watch the video at Investors.com - How To Find Game-Changing Stocks This proprietary rating tracks technical performance by showing how a stock's price ...
Oppenheimer raised the firm’s price target on Catalyst Pharmaceuticals (CPRX) to $31 from $29 and keeps an Outperform rating on the shares.
H.C. Wainwright analyst Andrew Fein raised the firm’s price target on Catalyst Pharmaceuticals (CPRX) to $35 from $30 and keeps a Buy rating on ...
Catalyst Pharmaceuticals, Inc. has announced a settlement agreement with Teva Pharmaceuticals, resolving the patent ...
Cullinan offers promising oncology and autoimmune products, strong financials, and potential for growth, making it a ...
Johnson & Johnson received Priority Review of nipocalimab in generalized myasthenia gravis. GSK’s B7-H3-targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback